These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30799422)

  • 1. A Rare Case of Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gastroesophageal Junction with HER2/neu Overexpression and Distinct Orbital and Optic Nerve Toxicity after Intravenous Administration of Cisplatin.
    Golombek T; Henker R; Rehak M; Quäschling U; Lordick F; Knödler M
    Oncol Res Treat; 2019; 42(3):123-127. PubMed ID: 30799422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed adenoneuroendocrine carcinoma (MANEC) of the gastroesophageal junction: a case report and review of the literature.
    Juanmartiñena JF; Fernández-Urién I; Córdoba A; Miranda C; Borda A
    Rev Esp Enferm Dig; 2017 Feb; 109(2):160-162. PubMed ID: 26999428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
    Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report.
    Semrau S; Agaimy A; Pavel M; Lubgan D; Schmidt D; Cavallaro A; Golcher H; Grützmann R; Fietkau R
    J Med Case Rep; 2019 Mar; 13(1):82. PubMed ID: 30902067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case of Esophagogastric Junction Adenocarcinoma with Neuroendocrine Differentiation].
    Kitano Y; Kinoshita J; Oyama K; Okamoto K; Sakai S; Makino I; Nakamura K; Hayashi H; Inokuchi M; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1226-1228. PubMed ID: 29394589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed adenoneuroendocrine carcinoma (MANEC) of the esophagogastric junction predominantly consisting of poorly differentiated neuroendocrine carcinoma.
    Veits L; Lang-Schwarz C; Volkholz H; Falkeis C; Vieth M; Schulz H
    Endoscopy; 2013; 45 Suppl 2 UCTN():E16-7. PubMed ID: 23468146
    [No Abstract]   [Full Text] [Related]  

  • 7. Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract.
    Araki T; Takashima A; Hamaguchi T; Honma Y; Iwasa S; Okita N; Kato K; Yamada Y; Hashimoto H; Taniguchi H; Kushima R; Nakao K; Boku N; Shimada Y
    Anticancer Drugs; 2016 Sep; 27(8):794-9. PubMed ID: 27341105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastric mixed adenoneuroendocrine carcinoma: a clinicopathological analysis of 36 cases].
    Gao R; Chen XY; Jin L
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):767-771. PubMed ID: 31594040
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic gastroesophageal junction adenocarcinoma to the extraocular muscles.
    Lekse JM; Zhang J; Mawn LA
    Ophthalmology; 2003 Feb; 110(2):318-21. PubMed ID: 12578774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Mixed Adenoneuroendocrine Carcinoma of the Gallbladder in a 55-Year-Old Female Patient: A Case Report and Review of the Literature.
    Acosta AM; Hamedani FS; Kajdacsy-Balla A; Wiley EL
    Int J Surg Pathol; 2015 Aug; 23(5):414-8. PubMed ID: 25838330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed Adenoneuroendocrine Carcinoma of the Gastroesophageal Junction: A Rare Find.
    Ambesh P; Weissbrot J; Ratner S; Sinha A; Patti R; Balderacchi J; Marcelin M; Wolf L; Kamholz S
    J Investig Med High Impact Case Rep; 2017; 5(4):2324709617750180. PubMed ID: 29318164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view.
    Fazio N; Spada F; Giovannini M
    Cancer Treat Rev; 2013 May; 39(3):270-4. PubMed ID: 22819619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
    Ajani JA; Komaki R; Putnam JB; Walsh G; Nesbitt J; Pisters PW; Lynch PM; Vaporciyan A; Smythe R; Lahoti S; Raijman I; Swisher S; Martin FD; Roth JA
    Cancer; 2001 Jul; 92(2):279-86. PubMed ID: 11466680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
    Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
    Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed adenoneuroendocrine carcinoma of the urethra.
    Raison N; McGovern U; Hines J; Volanis D
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30902843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report.
    Yamamoto M; Ozawa S; Koyanagi K; Oguma J; Kazuno A; Ninomiya Y; Yatabe K; Hatanaka K
    Surg Case Rep; 2018 Jun; 4(1):56. PubMed ID: 29900476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma.
    Madani SH; Rahmati A; Sadeghi E; Khazaei S; Sadeghi M; Payandeh M; Amirifard N
    Asian Pac J Cancer Prev; 2015; 16(17):7755-8. PubMed ID: 26625793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasms.
    Chen MH; Kuo YJ; Yeh YC; Lin YC; Tzeng CH; Liu CY; Chang PM; Chen MH; Jeng YM; Chao Y
    J Chin Med Assoc; 2015 Aug; 78(8):454-9. PubMed ID: 26002564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
    Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M;
    Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
    Norman G; Rice S; Spackman E; Stirk L; Danso-Appiah A; Suh D; Palmer S; Eastwood A
    Health Technol Assess; 2011 May; 15 Suppl 1():33-42. PubMed ID: 21609651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.